Actuate is a clinical-stage biopharmaceutical company focused on developing therapies for the treatment of high-impact, difficult-to-treat cancers, including pancreatic cancer and Ewing sarcoma.

Actuate Therapeutics (ACTU) has filed for up to 2,777,778 share offering by selling stockholders.

Jorge Arredondo was facing a charge of capital murder by terror threat/other felony. At a status hearing on Friday, Arredondo pleaded guilty to the charge and was ...

A dealership's rating is based on all of their reviews, with more weight given to recent reviews. Want to share your experience with this dealership? Robert Romero provided quick and excellent ...

The Edinburgh Festival Fringe is one of the greatest celebrations of arts and culture on the planet and takes place every August in Edinburgh, Scotland’s capital city. Find out more about how to make ...

CHICAGO and FORT WORTH, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Nasdaq: ACTU) (the “Company”), a clinical stage biopharmaceutical company focused on developing therapies ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

CHICAGO and FORT WORTH, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Nasdaq: ACTU) (the “Company”), a clinical stage biopharmaceutical company focused on developing ...